Diabetes-associated brain damage was reversed in rats treated with the red-wine compound
A team of cellular biologists are suggesting that red wine may help reverse some of the symptoms of cognitive decline in diabetics.
Published June 10 in the American Journal of Physiology, the study by scientists from Louisiana State University and the University of Nebraska Medical Center reported that diabetic rats that consumed the red-wine compound resveratrol experienced a restoration in brain function. Resveratrol, a polyphenolic compound that is abundant in red wine, has in the past been linked to reduced risk of diabetes, heart disease and certain cancers, as well as numerous other health benefits.
The risk of stroke and other brain disorders is higher in diabetics, regardless of type. Resveratrol is known to act as an anti-inflammatory and an antioxidant, the study states, which are associated with better circulation and a lower risk of cognitive decline. However, no previous studies explore whether resveratrol may potentially reduce risks associated with diabetes through its ability to regulate cerebral blood flow.
After several weeks of testing the circulation in the rats, before and after introducing resveratrol, the brains were harvested and examined. Brain tissue in diabetic rats treated with resveratrol showed that some of the brain damage associated with diabetes actually reversed after exposure to the red-wine compound.
"We speculate that resveratrol may be a potential therapeutic treatment for the prevention of cerebrovascular dysfunction during diabetes," the study states, concluding that there are three new findings to the research.
The first being that reservatrol appears to relax the arteries in the brain. In the case of rats with diabetes, without the resveratrol, blood vessels were comparatively more restricted.
Also, oxygen levels normalized in the diabetes-afflicted rats which consumed resveratrol, bolstering the assertion that the red-wine compound works as both an anti-inflammatory and antioxidant.
The third conclusion was that "resveratrol can decrease blood glucose concentration very modestly, less than 5 percent to 10 percent [in diabetic rats]," said Mayhan. "The mechanism is not known. We saw a small decrease in blood glucose concentration, but not enough to account for the effects of resveratrol."
Nonetheless, by controlling heavy levels of oxygen and keeping blood flowing to the brain, resveratrol may help control the stress factors that can lead to strokes in diabetics, the study speculated. However, the reactions of the diabetic brain to resveratrol may not be limited to the three factors observed, the scientists wrote.
There could, in fact, be much more going on that science has not yet discovered, and further study is necessary, as "it was beyond the scope of the present study to examine all such possibilities," the text read.
This article may be found at:
http://www.winespectator.com/webfeature/show/id/45392